SA’s medicines regulator has authorised five new Covid-19 antibody tests, which will help doctors retrospectively diagnose patients and provide a vital research tool for local vaccine trials.

The SA Health Products Regulatory Authority (Sahpra) announced on Monday that it had issued section 21 authorisation for laboratory-based antibody tests manufactured by Abbott Laboratories SA, Roche Diagnostics and Euroimmun Medical Laboratory Diagnostics SA. It has also authorised seven licence holders of Zhejiang Orient Gene Biotech’s rapid point of care antibody test...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.